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In renal failure studies revealed an increase in plasma concentration of lipoprotein(a)[ 
Lp(a)]. Elevated plasma Lp(a) levels in chronic renal failure patients is recognized as 
an independent risk factor for premature atherosclerotic coronary heart disease. In 
this study we aimed to consider the effect of serum plasma Lp(a) levels on early 
structural atherosclerotic vascular changes in a group of CRF patients not yet on 
dialysis and end-stage renal disease patients under regular hemodialysis.This study 
is cross-sectional which was done on chronic renal failure (CRF) patients not being 
on hemodialysis yet and hemodialysis patients who were underwent regular 
hemodialysis because of end-stage renal failure. For patients serum Lp(a) was 
measured. Carotid intima-media thickness (carotid-IMT) was measured and carotid-
femoral artery for plaque occurrence (plaque score) by B-mode ultrasonography was 
determined. Twenty-nine normal subjects (group one) (F=17 M=12), thirty-three 
chronic renal failure patients not yet on hemodialysis (group two)(F=19 M=14) and 
forty-three (F=19 M =24) hemodialysis patients due end-stage renal disease (group 
three) were considered. Mean±SD of LP(a) in group one were 42.0±20.0 mg/dl. The 
serum LP(a) of CRF group was 57.0±23.0 mg/dl and for HD group was 55.0±16.0 mg/dl. 
The IMT of group one was 0.84±0.20 mm.Mean±SD of IMT of CRF group and HD group 
were1.30±0.40 mm and 1.10±0.30 mm respectively. Ninety-three percent of persons of 
group one had zero plaque score while 39.4% of patients of group two and 51.2 %of 
patients in group three had zero plaque score more over 6.8% of subjects in group 
one, 24.3% in group two and 25.6% of patients in group three had plaque scores 
between 1&2. Also for plaque scores of 3&4, group one had zero plaque score, group 
two had 36.4% and group three had 23.3% plaques in scores of 3&4. Significant 
difference of IMT of group one with group two (p<0.001)and with group three (p=0.008) 
were seen. Significant difference of carotid- IMT of group two with group three 
(p=0.023) was found too. Significant difference of LP(a) of group one with group two 
(p=0.016) was seen and significant difference of LP(a) of group one with group three 
(p=0.021) was demonstrated too. No significant difference of LP(a) of group two with 
group three (p>0.05) were found. Significant differences of plaque score between 
group one with group two (p<0.001) was seen also significant difference of plaque 
score between group one with group three (p=0.020) was found. No significant difference 
of plaque score of group two with group three (p>0.05) was found. Significant 
positive correlation of serum LP(a) with carotid- IMT and also significant positive 
correlation of serum LP(a) with plaque score in hemodialysis patients were found. 
The present study showed positive relationship of serum LP(a) with carotid- IMT and 
arterial plaques in hemodialysis patients. Lipoprotein(a) as a non traditional factor in 
progression of atherosclerosis have an important role in acceleration of atherosclerosis 
and cardiovascular diseases observed frequently in hemodialysis patients and needs 
more attention. 
Key words: Intima-media Thickness, Lipoprotein(a), Hemodialysis, Chronic renal 
failure, Plaque score 
 
 
Introduction 
Lipoprotein(a) [Lp(a)] when present in high levels in 
plasma is recognized as an independent risk factor for 
premature atherosclerotic coronary heart disease (1). 
In renal failure studies revealed an increase in plasma 
concentration of Lp(a) (1-3). Elevated plasma Lp(a) 
levels in chronic renal failure patients have been 
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associated with a frequency distribution of apolipo-
protein(a) [apo(a)] isoforms Similar to those found 
in general population. This indicates that elevated 
Lp(a) levels in these patients are not due to genetic 
origin (4-6). Therefore it has been suggested that 
kidneys have an important role in Lp(a) metabolism, 
decrease Lp(a) catabolism or increase of liver 
production (7-10). Increased Lp(a) levels could be 
a contributing factor in the increased incidence of 
atherosclerotic disease observed in CRF and hemo-
dialysis patients (11-12). The early stages of arthero-
sclerosis are associated with changes in arterial 
structure. Subtle structural changes such as 
thickening of arterial intimae-media complex thickness 
(IMT) occur early in the atherosclerotic disease 
process (12-14). Using B-mode ultrasonography 
for assessing early athero-sclerosis is safe and non-
invasive to study superficial vascular districts, such 
as the carotid or femoral artery (11-13). Therefore 
ultrasonic evaluation of carotid artery for IMT can 
identify patients at risk for cardiovascular disease 
(12-14). Indeed carotid arteries are privileged area 
for studying the progression of atherosclerotic 
lesions from onset to fully developed plaque. 
Carotid- IMT measurements are strongly related to 
the extent of atherosclerosis in other vascular districts 
too (11-14). As many known and conventional risk 
factors have been shown to be significantly associated 
with increased arterial wall thickness, consistent 
with their accepted role in atherogenesis, much less 
is known however about the effects of Lp(a) on 
IMT of CRFand hemodialysis (HD) patients (15). 
Therefore in this study we firstly aimed to consider 
the effect of plasma Lp(a) levels on early structural 
atherosclerotic vascular changes in a group of CRF 
patients not yet on dialysis and end-stage renal 
disease patients under hemodialysis and secondly 
we aimed to consider the correlation of Carotid 
artery-IMT and carotid-femoral artery plaques with 
other lipids mentioned in the study and duration of 
disease.   
Patients and Methods 
This is a cross-sectional study that was carried out 
on patients with chronic renal failure not yet on 
dialysis and end-stage renal disease patients under-
going maintenance hemodialysis treatment. For 
patient selection exclusion criteria were cigarette 
smoking, body mass index more than 25, anti lipid 
drug taking, recent MI and vascular diseases and 
also active or chronic infection and diabetes mellitus 
were the other exclusion criteria. Group one were 
healthy persons who had no history of hypertension 
or renal disease. Group two were chronic renal 
failure(CRF) patients not being on hemodialysis 
yet and group three were hemodialysis patients 
who were underwent regular hemodialysis because 
of end-stage renal failure. For laboratory exams, 
after 14 hour overnight fasting blood sampling 
were done. For group one and two blood sampling 
were done from antecubital vein for group three 
blood samples were obtained from venous line of 
hemodialysis apparatus at the beginning of hemo-
dialysis. Fasting blood suger (FBS), lipoprotein (a) 
[Lp (a)], Triglyceride (TG), Cholestrol (Chol), 
HDL-C, LDL-C, Bun, Creatinin were measured. 
Lp(a) was measured by enzyme immunoassay 
(ELISA) by Immuno-biological laboratories (IBL) 
kit of Hamburg. Oher lipids mentioned above and 
BUN, Creatinin and FBS were measured by 
standard kits. Serum LDL-C was calculated by 
friedewald's formula (16). Creatinine clearance 
was evaluated from serum creatinine, age and body 
weigh (17). Subjects in group one were interviewed 
using a questionnaire prior to consent ascertain that 
were free from any clinical evidence or history of 
diabetes, cardiac or vascular disease and had no 
past or current history of hypertension or any renal 
disease. The clinical history of patients in groups 
two and three was determined by medical records 
of hospital. Carotid and femoral artery sonography 
were done by a single sonologist unaware of 
history or lab data of patients. Using a Honda-Hs-
2000 Sonograph with 7.5 MHZ linear probe IMT 
in mm was measured and carotid-femoral arterial 
plaque (plaque score) were determined. The procedure 
was done at the end of diastolic phase. The sites of 
measurements were at the distal common carotid 
artery, area of bifurcation and at the first proximal 
internal carotid artery. Carotid-IMT was measured 
at the plaque free areas. For examination. Subjects 
were in supine position with neck hyperextension 
and rotation of head for facilitation of procedure 
performing. By sonography, the carotid artery 
found to has tree different echoes. Intimae- media 
thickness (IMT) was defined as the distance from 
leading edge of lumen-Intimae interface of the far 
wall to the leading edge of the media- adventitia 
interface of the far wall. Caritid-IMT more than 0.8 
mm was considered abnormal. For statistical 
analysis we considered the mean of right and left 
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carotid artery- IMT. Sonography for plaque was 
done at the right and left of carotid and femoral 
arteries and scored from 0 (no plaque) to score 4 
(plaque presence at all four sites) regardless of the 
number and size of the plaques in each site plaque 
occurrence in each site scored one point plaques 
was considered as a local intimal thickness more 
than 1 mm. For plaque measurement the largest 
longitude was considered. For statistical analysis 
descriptive data are expressed as Mean±SD and 
frequency distributions. For comparison between 
groups ANOVA, Scheffe and Chi-Square tests 
were used. For correlations partial correlation test 
with adjustment for age and regression analysis 
with stepwise method were used and all statistical 
analysis were performed using SPSS (version 
11.00). Probability (p) was considered significant 
when p< 0.05. 
Results 
The total subjects were 105 (F=55 M=50) consisting 
of 29 normal, healthy subjects (control group= 
group one) (F=17 M=12) 33 chronic renal failure 
patients not yet on hemodialysis (CRF group= 
group two) (F=19 M=14) and 43 hemodialysis 
patients due end-stage renal disease (HD group= 
group three) (F=19 M =24). Table 1 show the 
characteristics of subjects. Table 2 show the 
mean±SD of laboratory data of subjects. Table 3 
show the frequency distribution of plaque score in 
subjects. Mean±SD of known duration disease in 
CRF patients were36±20 months. Mean±SD of the 
length of the time patients have been on hemo-
dialysis were 44±31 months. Group one had normal 
creatinin clearance, Mean±SD of creatinin clearance 
of group two were 31±18 and for HD group the 
creatinin clearance of below 10 cc/min was envi-
saged. The serum LP(a) in group one and CRF 
group and also in HD group were 42.0±20.0 and 
57.0±23.0 mg/dl and 55.0±16.0 mg/dl respectively. 
Mean±SD of carotid- IMT in group one was 
0.84±0.20 mm. The carotid- IMT of CRF and HD 
group were 1.30±0.40 mm and 1.10±0.30 mm 
respectively. Ninety-three percent of subjects of 
group one had zero plaque score while 39.4% of 
patients of group two and 51.2 %of patients in 
group three had zero plaque score and also 6.8% of 
subjects in group one, 24.3% of patients in group 
two and 25.6% of patients in group three had 
plaque scores between 1&2. More over for plaque 
scores of 3&4 group one had zero plaque score 
group two had 36.4% and group three had 23.3% 
plaques in scores of 3&4. All of the plaques were 
calcified. By ANOVA there were significant 
difference of carotid- IMT (p<0.001), LDL-C 
(p<0.001), Cholestrole (p<0.001), and LP(a) (p=0.006) 
between three groups. No significant difference of 
Triglycerid (TG) and HDL-C between three groups 
were found (p>0.05). Significant difference of 
carotid- IMT of group one with group two (p<0.001) 
was seen and significant difference of carotid- IMT 
of group one with group three (p=0.008) was 
demonstrated too. More over significant difference 
of carotid- IMT of group two with group three 
(p=0.023) was found (Scheffe test). Significant 
difference of serum LP(a) of group one with group 
two (p=0.016) was found and significant difference 
of serum LP(a) of group one with group three 
(p=0.021) was seen too and no significant diffe-
rence of carotid- IMT of group two with group 
three (p=0.962) was found (Scheffe test). Signi-
ficant differences of plaque score between three 
groups (p= 0.02) (Chi-Square test) were seen. 
Scheffe test showed significant difference of group 
one with group two (p<0.001) and also significant 
difference of group one with group three (p=0.020) 
was demonstrated and no significant difference of 
plaque score of group two with group three (p>0.05) 
was found. Ninety-eight percent of patients in 
groups two and three were hypertensive that were 
taking antihypertensive therapy and were near 
control.Mean ±SD of systolic blood pressure in 
group two and three were 130 ± 20 mmHg. Mean± 
SD of diastolic blood pressure in group two and 
three were 80±20 mmHg there was not significant 
difference between hypertention of group two with 
three (p>0.05). There was a significant positive 
correlation between IMT and age in group one 
(p=0.035), group two (p=0.017) and group three 
(p=0.019) (regression analysis with stepwise method). 
In normal persons significant positive correlation 
of carotid- IMT with LDL-C (r =0.350 p= 0.03) 
was seen and significant linear inverse correlation 
of carotid-IMT with HDL-C (r = -0.405 p= 0.02) 
was found too and also marginal correlation of 
carotid-IMT with TG (r =0.310 p= 0.05) were 
found. No significant positive correlation of 
carotid-IMT with serum LP(a) (r =0.240 p> 0.05) 
was demonstrated and no significant positive 
correlation of carotid-IMT with serum Chol (r = 
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0.260 p>0.05) were found too, more over no 
positive correlation of carotid-IMT with plaque 
score (r =0.101 p>0.05 ) was found in this group 
also no positive correlation of plaque score with 
serum LP(a) , LDL-C, HDL-C, Chol and TG were 
found too (p>0.05) (Partial correlation test after 
adjustment for age). In CRF group significant 
positive correlation of carotid-IMT with plaque 
score (r =0.500 p= 0.002) was seen. No positive 
correlation of carotid-IMT and also plaque score 
with serum LP(a), LDL-C, HDL-C, Chol and TG 
were found (p>0.05) (partial correlation test after 
adjustment for age, Clearance of Creatinin and 
known duration of disease) in CRF group. In this 
group significant linear inverse correlation of 
creatinin clearance with serum LP(a) (r = -0.441 
p= 0.040) (Figure 1) was seen. No significant 
positive correlation of carotid-IMT and also plaque 
score with Creatinin Clearance (p>0.05) were 
found (partial correlation test after adjustment for 
age) in CRF group. In HD group, significant 
positive correlation of carotid-IMT with serum 
LP(a) (r =0.298 p= 0.029) (Figure 2) was found. 
Significant positive correlation of plaque score 
with serum LP(a) (r =0.375 p= 0.008) (Figure 3) 
was found too in hemodialysis patients. No signi-
ficant positive correlation of carotid-IMT and also 
plaque score with Chol , LDL-C, HDL-C, and TG 
were found in HD patients (p>0.05), more over no 
significant positive correlation of carotid- IMT with 
plaque score (r =0.222 p>0.05) was found (partial 
correlation test after adjustment for age) in this 
group. 
Table 1. Frequency distribution of Ag (year), D.D: duration of disease 
(months) and Clearance of Creatinin (CLcr) (cc/min).  
Variables mean±SD Minimum Maximum 
Group 1 
Age 
D.D 
CLcr 
IMT 
45 ±10.4 
- 
103±4 
0.84±0.20 
20 
- 
98 
0.50 
70 
- 
110 
1.20 
Group 2 
Age 
D.D 
CLcr 
IMT 
62±14.5 
36±20 
31±18 
1.30±0.40 
30 
2 
10 
0.60 
88 
76 
70 
2.0 
Group 3 
Age 
D.D 
CLcr 
IMT 
47±16.4 
44 ±31 
<10 
1.10±0.30 
15 
6 
<10 
0.50 
78 
108 
<10 
1.70 
D.D in group two:  Known duration of CRF. 
D.D in group three: The length of the time patients had been on 
hemo-dialysis. 
Table 2. Frequency distribution of lipids (mg /dl). 
Variables Mean±SD Minimum Maximum 
Group 1 
Lp (a) 
Chol 
LDL-c 
HDL-c 
Tg 
42.0±20.0 
203±41 
126±34 
41±10 
154±73 
 
10 
125 
75 
25 
50 
 
94 
340 
230 
65 
325 
 
Group 2 
Lp (a) 
Chol 
LDL-c 
HDL-c 
Tg 
57.0±23.0 
211±70 
136±52 
33±13 
171±100 
15 
100 
45 
15 
60 
135 
390 
300 
85 
550 
Group 3 
Lp (a) 
Chol 
LDL-c 
HDL-c 
Tg 
55.0±16.0 
148±35 
97±28 
33±18 
145±62 
25 
95 
40 
20 
40 
95 
930 
160 
90 
230  
 
Table3. Frequency distribution of plaque score in groups. 
plaque score Frequency Percent 
0 27 93 
1 1   3.4 
2 1   3.4 
3 0   0 
Group 1 
4 0   0 
0 13 39.4 
1 5 15.2 
2 3   9.1 
3 3   9.1 
Group 2 
4 9 27.3 
0 22 51.2 
1 3   7 
2 8 18.6 
3 2   4.7 
Group 3 
4 8 18.6 
 
 
            Clearance  of Creatinine   cc/min
80706050403020100
   
   
   
   
   
   
   
 L
ip
op
ro
te
in
(a
)  
 m
g/
dl
140
120
100
80
60
40
20
0
 
Figure 1. Significant linear inverse correlation of LP(a) with 
Clearance of Creatinine in CRF group(Group 2), [partial 
correlation test after adjustment for age (r = -0.441 p= 0.06)]. 
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Figure 2. Significant positive correlation of carotid- IMT with serum 
LP(a) in hemodialysis patients (r =0.298 p= 0.029) 
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Figure 3. Significant positive correlation of plaque score with serum 
LP(a) in hemodialysis patients (r =0.375 p= 0.008). 
Discussion 
The principle findings of this study were firstly 
higher serum levels of lipoprotein (a), more 
thickening of carotid intima- media complex and 
more plaque occurrence of carotid-femoral artery 
in patients involved by chronic renal failure either 
predialysis or on hemodialysis, secondly positive 
correlation of serum LP(a) with carotid- IMT and 
plaque score only in hemodialysis patients. Pascasio 
et al. observed a large number of vascular plaques 
in uremia patients, he concluded that the process of 
advance atherosclerosis might be started with the 
beginning of renal failure, he suggested that hemo-
dialysis treatment may not a potential factor to 
accelerate arthrosclerosis. Finally he concluded that 
the progression of atherosclerosis might be related 
to atherogenic factors operative before regular 
dialysis (18). Damjanovic et al. evaluated IMT of 
45 dialysis patients found higher mean carotid IMT 
in HD patients than in control group. He showed 
positive correlation of IMT with certain risk factors 
for atherosclerosis (age, duration of dialysis and 
lipid parameters) (19). Correlation of IMT with 
ages and duration of hemodialysis in HD patients 
was evaluated, by Shoji and Hojs et al. no clear 
relationship of IMT with duration of hemodialysis 
treatment were found in their studies (20,21). Hojs 
also in his study (28 HD patients) observed, age 
was the only significant determinant of number of 
plaques, he concluded that hemodialysis patients 
had advanced atherosclerosis in the carotid arteries 
compared with normal subjects (21). More over 
Hojs in a recent study, showed no difference in 
plaque occurrence between 28 hemodialysis patients 
with 28 ESRD patients prior to hemodialysis (22). 
Savage et al. In a study on 24 dialysis patients 
noted on more prevalence of plaque in carotid and 
femoral artery, also this study showed the relationship 
between femoral artery plaque and ages of the 
subjects. Also he showed the correlation of age 
with IMT of carotid artery of HD patients (23). 
Moreover in a recent study by Kato et al. showed a 
significant correlation of IMT with age on 219 HD 
patients (12). Papagianni et al. in a study on 112 
HD patients. showed a positive correlation of plaque 
score with age of the subjects (13). The present 
study showed positive relationship of LP(a) with 
IMT and also no clear relationship between LP(a) 
with IMT of CRF group was observed, while no 
differences between LP(a) and IMT of CRF and 
HD patients were found. Studies concerning the 
effect of LP(a) on IMT of normal persons showed 
various results. Sramek et al. on 142 asymptomatic 
men found no increased IMT in the carotid or 
femoral artery at high levels of Lp (a) he concluded 
that, Lp(a) levels are not associated with early 
atherosclerotic vessel wall changes in the carotid 
or femoral arteries (24). Dentil et al. in a study on 
100 elderly subjects (aged 78.5±0.6), showed no 
association between carotid IMT and Lp (a), he 
concluded that the Lp (a) was unrelated to the 
severity of extra cranial vessels atherosclerosis (25) 
while Baldassarre et al. in a study on 100 type 2 
hypercholestrolemic patients showed higher values 
of carotid IMT in hyrercholestrolemic patients with 
plasma Lp (a) levels > 30 mg/dl than in those with 
lower levels. He concluded that elevated plasma 
levels of Lp (a) can be considered an additional 
independent factor associated with thickening of 
carotid artery in patients with severe hyper-
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cholesterolemia but not in those with moderate 
hypercholesterolemia or normocholestrolemic 
subjects (26). Finally Raitakari et al. on 241 healthy 
subjects suggested no association between IMT 
and Lp (a) but significant positive correlation with 
total Cholesterol, LDL-c, LDL/HDL ratio, age, and 
Tg were found (1). In renal failure patients the 
process of accelerated atherosclerosis is frequently 
seen. As the extraordinary high mortality in end-
stage-renal disease (ESRD) patients under hemo-
dialysis are due to cardiovascular disease ,there is 
some interest toward non traditional atherosclerotic 
cardiovascular disease risk factors that are Prevalent 
in ESRD Such as Lipoprotein(a) which needs to 
more attention because of its effect to acceleration 
of rapid progressive atherosclerosis seen in HD 
patients. 
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